ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin

Apramycin is an aminoglycoside antibiotic with the potential to be developed to combat multidrug-resistant pathogens. Its unique structure evades the clinically widespread mechanisms of aminoglycoside resistance that currently compromise the efficacy of other members in this drug class. Of the amino...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordeleau, Emily, Stogios, Peter J., Evdokimova, Elena, Koteva, Kalinka, Savchenko, Alexei, Wright, Gerard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885111/
https://www.ncbi.nlm.nih.gov/pubmed/33563840
http://dx.doi.org/10.1128/mBio.02705-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885111/
https://www.ncbi.nlm.nih.gov/pubmed/33563840
http://dx.doi.org/10.1128/mBio.02705-20

Ejemplares similares